Related Experiment Videos

TH1 and TH2 CD4+ cells in human allergic diseases

D T Umetsu¹, R H DeKruyff

¹Department of Pediatrics, Stanford University, Calif, 94305-5119, USA.

The Journal of Allergy and Clinical Immunology

|July 1, 1997

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018

TIM-4, expressed by medullary macrophages, regulates respiratory tolerance by mediating phagocytosis of antigen-specific T cells.

Mucosal immunology·2012

Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab.

Mucosal immunology·2012

99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: microbes, apoptosis and TIM-1 in the development of asthma.

Clinical and experimental immunology·2010

PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.

Mucosal immunology·2009

Natural killer T cells and the regulation of asthma.

Mucosal immunology·2009

See all related articles